Digital health program to reduce early heart and kidney risks
Part of Heart & circulation clinical trials.
This trial tests a digital-health (phone/app or similar) program to help detect and manage early, mild organ damage and reduce future cardiovascular risk. It may help you understand your risk earlier and stay on track with follow-up over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You are willing to join and sign the informed consent form
- You can commit to long-term follow-up visits/monitoring
- You do not have severe heart failure (NYHA class IV)
- You do not have advanced kidney disease (stage 4 or 5)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a digital heart health app combined with lifestyle coaching to help people with heart disease or diabetes manage their cholesterol and overall heart health. It aims to see if the app can improve outcomes for people already taking a statin.
This trial tests a digital program to help people aged 40–60 make healthy changes like eating better, moving more, or managing stress. It’s designed to prevent heart problems before they start.
This trial tests a digital health management program for people with early-stage high blood pressure, prediabetes, obesity, or mild high cholesterol who aren't yet on medication. It aims to help you manage these conditions through your smartphone.
This study compares a new way to manage heart disease risk factors using digital technology (like apps or remote monitoring) with the traditional doctor visit approach. It aims to see which method better helps people control high blood pressure, blood sugar, cholesterol, and weight over 2 years.
This trial tests a digital program led by nurses to help manage heart disease risk. You use a smartphone or tablet to track your health at home, and the nurse team checks in remotely.
This study tests a smartphone and wearable-based health management platform for people with early-stage cardiovascular-kidney-metabolic (CKM) syndrome. It aims to help patients track and improve their health through personalized support.
Hear when a new Cardiovascular Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.